Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.910
-0.030 (-1.55%)
Mar 31, 2025, 9:51 AM EDT - Market open
Innate Pharma Revenue
In the year 2024, Innate Pharma had annual revenue of 20.12M EUR, down -67.36%. Innate Pharma had revenue of 7.78M in the half year ending December 31, 2024, a decrease of -35.66%.
Revenue (ttm)
20.12M EUR
Revenue Growth
-67.36%
P/S Ratio
8.11
Revenue / Employee
112,408 EUR
Employees
179
Market Cap
169.04M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.12M | -41.52M | -67.36% |
Dec 31, 2023 | 61.64M | 3.97M | 6.88% |
Dec 31, 2022 | 57.67M | 32.97M | 133.47% |
Dec 31, 2021 | 24.70M | -45.07M | -64.60% |
Dec 31, 2020 | 69.77M | -15.68M | -18.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
IPHA News
- 3 days ago - Innate Pharma S.A. (IPHA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Innate Pharma Reports Full Year 2024 Financial Results and Business Update - Business Wire
- 5 days ago - Innate Pharma Highlights Antibody Drug Conjugate IPH4502 Abstract Selected for the AACR 2025 Annual Meeting - Business Wire
- 6 days ago - Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference - Business Wire
- 10 days ago - Innate Pharma: Moving Into The Padcev Space - Seeking Alpha
- 11 days ago - Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results - Business Wire
- 4 weeks ago - Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference - Business Wire
- 5 weeks ago - Innate: Lacutamab Treatment Program Moves Forward With Potential Expansion - Seeking Alpha